Publication

Can Use of Viral Load Improve Norovirus Clinical Diagnosis and Disease Attribution?

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Kayoko Shioda, Centers for Disease Control and PreventionLeslie Barclay, Centers for Disease Control and PreventionSylvia Becker-Dreps, University of North CarolinaFilemon Bucardo-Rivera, National Autonomous University of LeonPhilip J. Cooper, Universidad Internacional del Ecuador QuitotoDaniel C. Payne, Centers for Disease Control and PreventionJan Vinje, Centers for Disease Control and PreventionBenjamin Lopman, Emory University
Language
  • English
Date
  • 2017-06-01
Publisher
  • Oxford University Press Inc.
Publication Version
Copyright Statement
  • © Published by Oxford University Press on behalf of Infectious Diseases Society of America 2017.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 4
Issue
  • 3
Start Page
  • ofx131
End Page
  • ofx131
Grant/Funding Information
  • The following funding sources were put together for the study in Nicaragua: the Merck Investigator-Initiated Studies Program for laboratory analysis; the Thrasher Research Fund for field work; Grant 5K01TW008401-04 from the Fogarty International Center at the National Institutes of Health (to S. B.-D.); and NETROPICA (Grant 05-N-2010; to F. B.-R.).
  • Data and sample collection in Ecuador were funded by Wellcome Trust (Grant 088862/Z/09/Z; to P. C.).
  • This work was supported by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and CDC to (to K. S.).
Supplemental Material (URL)
Abstract
  • Background: Real-time reverse-transcriptase polymerase chain reaction (RT-PCR) is the state-of-the-art diagnostic for norovirus. Cycle threshold (Ct), an indicator of viral load, may be associated with symptomatic disease as well as demographic and outbreak characteristics. Methods: Data on (1) outbreak and sporadic cases and (2) asymptomatic controls in the United States and Latin America were analyzed. With multivariate regression models, we assessed relationships between various factors and Ct values, and we calculated odds ratios (ORs) for the presence of symptoms and attributable fractions of norovirus. Receiver-operating characteristic analysis was performed to define an optimal Ct cutoff to identify disease-causing infections. Results: Cycle threshold values were lower (ie, higher viral loads) among symptomatic cases (model-adjusted mean ± standard error: 25.3 ± 1.2) compared with asymptomatic controls (28.5 ± 1.4). Cycle threshold values were significantly different across age groups, norovirus genogroups, timing of specimen collection, outbreak settings, and transmission modes. Genogroup II (GII) Ct values were associated with presence of symptoms (OR = 1.1), allowing us to estimate that 16% of diarrheal disease was attributable to norovirus. The optimized Ct cutoff led to poor sensitivity and specificity for genogroup I and GII. Conclusions: Cycle threshold values were associated with host, pathogen, and outbreak factors. Cycle threshold values may not effectively distinguish disease-causing infection for individual patients, but they are useful for epidemiological studies aiming to attribute disease.
Author Notes
  • Correspondence: K. Shioda, DVM, MPH, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS A-34, Atlanta, GA 30329 (kayoko.shioda@gmail.com)
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Microbiology
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items